About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
26 11, 2025

10 Best Collagen Powders, According to Doctors and Dietitians

By |2025-11-26T19:40:09+02:00November 26, 2025|Dietary Supplements News, News|0 Comments


✔️ Consider collagen source: Some packaging disclaims the type of collagen within, for example, type I or type II. “There are a few different types of collagen, but the primary ones are known as types I, II, and III,” explains Jones. “Some research suggests the benefits of type I and type III collagen supplements are mainly related to muscle growth and support, weight management, beauty, and skin, while type II is best for supporting healthy joints.”

✔️ Look for the words “collagen peptides” or “hydrolyzed collagen”: “Not all collagen is created equal,” says Jones. “This means the collagen is put through a special production process that hydrolyzes the collagen protein into smaller components, called peptides. Peptides are microscopic bundles of amino acids that are easier for the body to absorb–which means you get the most benefits!”

✔️ Know that collagen powders are not plant-based: Collagen powders are derived from animals, and there are currently no vegan or vegetarian-friendly supplements on the market. However, there are plant-based supplements that may help boost the body’s natural collagen production.



Source link

26 11, 2025

ETHUSD Price Prediction: Is a Rebound to $3605 Likely?

By |2025-11-26T19:33:10+02:00November 26, 2025|Crypto News, News|0 Comments

Ethereum (ETHUSD) has experienced a sharp decline, shedding 5.13% to trade at $2801.14. This drop comes amid increased volatility, sparking interest in its short-term price trajectory. As we dissect the numbers and technical indicators, we explore whether Ethereum can rebound to its monthly forecast of $3605.28.

Current Market Performance

Ethereum is currently priced at $2801.14, reflecting a decrease of 5.13% from its previous close at $2952.53. The recent trading session saw ETHUSD dip to a low of $2766.72 before climbing to a high of $2857.19. With a market cap of $351.93 billion and a trading volume of $20.36 billion, Ethereum’s current levels pose questions on its potential recovery.

Technical Analysis: Indicators and Signals

Technical indicators for Ethereum highlight a challenging phase. The RSI stands at 36.55, suggesting it is nearing oversold territory, while the MACD is at -285.64, indicating a bearish sentiment with a strong trend as shown by an ADX of 50.25. Bollinger Bands are narrowing, with the lower band at 2662.11, pointing to a potential support level. However, volatility remains high, as indicated by an ATR of 262.58. Forecasts can change due to macroeconomic shifts, regulations, or unexpected events affecting the crypto market.

Market Forecasts and Future Outlook

Looking ahead, Ethereum’s monthly forecast suggests a potential rise to $3605.28. However, the quarterly and yearly projections of $3457.18 and $3429.94 respectively, emphasize a cautiously optimistic outlook. Long-term predictions by Meyka AI, an AI-powered platform, show Ethereum climbing to $4169.63 in three years and $4912.25 in five years. Current bearish momentum is influenced by broader market trends, but recovery could be on the horizon.

Implications of Recent News

Recent news from Yahoo Finance highlights Ethereum’s fluctuating supply and recent price stagnation. This backdrop aligns with current bearish trends, influenced by wider economic factors. Ethereum’s current supply stands at 120,695,601.134, adding a layer of complexity to its market dynamics. External factors such as regulatory changes could disrupt or bolster Ethereum’s position in the coming months.

Final Thoughts

Ethereum’s recent price drop has raised concerns, but the underlying data suggests potential recovery. While current market indicators are bearish, price forecasts offer hope for a rebound. Traders should remain aware of macroeconomic influences that could rapidly alter these predictions.

FAQs

What is the current ETHUSD price?

The current price of ETHUSD is $2801.14, reflecting a 5.13% decline from its previous close of $2952.53.
Explore more on ETHUSD.

What do the technical indicators suggest for Ethereum?

Technical indicators show Ethereum in a bearish trend with an RSI of 36.55 and a MACD of -285.64, indicating possible oversold conditions soon. An ADX of 50.25 confirms a strong trend.

What are Ethereum’s price predictions for the near future?

Ethereum’s monthly forecast targets a price of $3605.28, while longer-term projections are optimistic, with potential to reach $4169.63 in three years.

How does recent news affect Ethereum’s outlook?

Recent news indicates fluctuating supply and a stable price range, influencing the market’s bearish mood. Regulatory changes may impact Ethereum’s future trends.

Why has ETHUSD recently declined?

The decline in ETHUSD to $2801.14, down 5.13%, is attributed to market volatility and broader economic influences reflected in decreased trading volumes.

Disclaimer:


Cryptocurrency markets are highly volatile. This content is for informational purposes only.
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice.
Meyka AI PTY LTD provides market data and sentiment analysis, not financial advice.
Always do your own research and consider consulting a licensed financial advisor before making investment decisions.

Source link

26 11, 2025

Sateria Venable Talks Fibroids and Fertility

By |2025-11-26T19:12:18+02:00November 26, 2025|Fitness News, News|0 Comments

Painful periods. Flood-like flows. Uterine growths the size of a melon. We know this sounds like a bad premenstrual dream, but these are just a few of the life-altering symptoms associated with uterine fibroids.

Sateria Venable knows firsthand how disruptive fibroids can be. Before she was founder and CEO of The Fibroid Foundation, Venable was on her third surgery to remove fibroids that kept coming back. She also had a hard time finding healthcare providers who specialized in treating fibroids or anyone who would talk to her about fertility-sparing treatments. She was only 26.

Venable felt completely alone. At that time, she had no idea that up to 8 in 10 women will develop fibroids by age 50. It was only when Venable began detailing her experience with fibroids online that she realized that she wasn’t alone — and there were a lot of women looking for answers.

In 2013, Venable started The Fibroid Foundation as a way to bring the community together and advocate for a cure and policy changes to improve the lives of people with fibroids.

Now, 12 years in, The Fibroid Foundation has expanded to reach 181 countries and continues to advocate for research and legislation including leading the efforts to introduce The Fibroid Bill into the U.S. House of Representatives and the Senate.

We talked to Venable about the progress in fibroid health she’s seen over the years and what women need to know about this common gynecologic condition.

Our interview follows, edited for clarity and length.

HealthyWomen: Your LinkedIn profile says you turned your uterine fibroids diagnosis into a global movement by founding The Fibroid Foundation. How did your experience inspire you to start the organization?

Sateria Venable: Well, I was a frustrated patient. I’d just had my third fibroid surgery, and I guess I was just kind of shocked that the fibroids kept returning.

The third surgery was an open myomectomy, which is where your abdomen is cut open, your uterus is lifted out of your body, the fibroids are cut out of your uterus, the uterus is sewn back together and put back into your body. And it’s as horrible as it sounds.

There are women who go through multiple myomectomies in effort to conceive, but I had such a hard time finding someone to do the surgery — rather than just offer a hysterectomy — and I lived in Chicago. At the time, I thought if I’m in a major metropolitan city, and I’m having challenges finding a fibroid surgeon, just what is going on?

I started blogging my experience month to month, because month to month it was very different. I had severe anemia from heavy periods, then surgery and recovery. And once I started blogging, women started to really speak up and say, ‘The same things are happening to me.’

I thought I was alone and that’s when I thought I need to formalize this experience that I’m having and try to help other women as well.

HW: Through the foundation, you advocate for more than 26 million women in the United States and people with fibroids around the world. What’s new in fibroid innovation that you want women to know?

Venable: I really want them to be aware that there are medical therapies. I think one of the most pressing issues is if you have symptomatic fibroids, there could be severe anemia. A lot of women and menstruators are diagnosed with fibroids when they are in crisis, and doctor Elizabeth Stewart at Mayo Clinic advised me that it’s not a good idea to make decisions when you’re in crisis because you feel rushed.

A lot of women and menstruators who are diagnosed with fibroids are hearing the word “fibroid” for the first time. And then on top of wrapping their minds around what that means, they then have to start to learn about treatment options while they’re not feeling well.

So, the innovation that I really feel needs more attention is the medical therapies that were approved during the pandemic. In the healthcare arena we refer to them as medical therapies but the term “fibroid pill” seems to resonate more with our community.

There were two pills from two different manufacturers that were approved, and I see them as tools in a toolkit where if you’re severely anemic and you are needing to prepare for surgery or trying to understand what steps to take and you’re not feeling well, you can take this medical therapy specifically for fibroids that will greatly or drastically reduce your period or stop it altogether to give your body a chance to recover so that you can then have a clear mind about what steps you’d like to take next.

And it’s also a great bridge through perimenopause. All women — not just women with fibroids —- can experience some very heavy menstrual flows and that can be very disruptive to anyone’s lifestyle. And so the medical therapies can help to stabilize that as well.

Read: Comic: Annie Has Anemia >>

HW: You’ve said in past interviews that a hysterectomy is not the only solution for addressing fibroids. What do you want women to know about treatment options?

Venable: I think the most important thing is finding the right information and the right provider.

Oftentimes, at the foundation, we’re contacted by women who say that they have one or two fibroids and the only option they were given is a hysterectomy. And then on the opposite end of that spectrum, we have a medical advisory board and some of those physicians have removed 30, 40, 50 fibroids and left the uterus intact.

I think it’s very, very important that women diagnosed with fibroids need to either find a fibroid specialist or a reproductive endocrinologist, which is another specialty that is particularly useful for women and menstruators who would like to conceive.

HW: As a leader in the women’s health community, what’s the toughest thing about activism?

Venable: In the earlier part of my career — because I don’t have a healthcare background — I was in the construction management arena, and having the courage to switch gears and follow my heart and address this need has added a quality of life to my life that makes everything feel like it’s just flowing in the right direction.

And so I never think about activism being tough. It’s just really a joy and a privilege. And for me personally, it checks all the boxes of being inquisitive and giving back.

I’m grateful to be able to be in this role and to see the change that we’ve been able to bring forth.

HW: Tell us the biggest misconception about fibroids you’d like to correct.

Venable: The biggest misconception is that this is just a Black woman’s disease. Fibroids impact every single ethnicity, and we don’t even have the data to show the true impact for most communities, but with The Fibroid Foundation reaching over 180 countries around the world, it’s clear that our community crosses cultures and multiple ethnicities.

Take our quiz: True or False: Uterine Fibroids >>

HW: In addition to CEO and patient advocate, you’re also an inventor. Tell us about the undergarment you designed specifically for women with fibroids.

Venable: It’s a series of undergarments for women with heavy flow issues post- maternity and light incontinence, and so we’re looking at them being pretty as well as functional.

The product is not out there yet, but we’re close. We’re actually in the process of looking at the best place to source the undergarment and that’s an ongoing process.

I would like to see it launched next year and it has taken some time, but I feel really good about where we are and the team that we’re working with. I’ll keep you posted on how that progresses and hope that again, what we’ve learned will help us deliver a product that will be very helpful to our community at large.

From Your Site Articles

Related Articles Around the Web



Source link

26 11, 2025

Forecast update for EURUSD -26-11-2025.

By |2025-11-26T18:10:02+02:00November 26, 2025|Forex News, News|0 Comments


The EURJPY pair is forced to provide weak sideways trading, affected by the contradiction between the main indicators, keeping its stability near 180.80, reminding you that the negative stability below 181.75 barrier forms main factors to motivate the dominance of the bearish corrective trend, to expect the attempt of pressing on 179.40 level, where surpassing it will form next main target at 178.60 for the bearish trading.

 

While breaching the mentioned barrier and holding above it will increase the chances of resuming the main bullish trend, to expect recording extra gains by its rally towards 182.30 and 183.05.

 

The expected trading range for today is between 179.30 and 181.10

 

Trend forecast: Bearish





Source link

26 11, 2025

EUR/USD Analysis Today 26/11: Remains Cautious (Chart)

By |2025-11-26T17:48:07+02:00November 26, 2025|Forex News, News|0 Comments

EUR/USD Analysis Summary Today

  • Overall Trend: : Bearish.
  • EUR/USD Support Levels Today: 1.1500 – 1.1430 – 1.1350
  • EUR/USD Resistance Levels Today: 1.1600 – 1.1660 – 1.1780

EUR/USD Trading Signals:

  • Buy EUR/USD from the support level of 1.1460 with a target of 1.1700 and a stop-loss at 1.1380.
  • Sell EUR/USD from the resistance level of 1.1660 with a target of 1.1400 and a stop-loss at 1.1780.

Technical Analysis of EUR/USD Today:

Improved investor sentiment amid signals of a potential resolution to the Russian-Ukrainian conflict gave EUR/USD bulls enough momentum to launch gains to the 1.1568 resistance level during yesterday’s trading session. The pair is stable around these gains at the time of writing this analysis, amidst mixed results from the US economic releases, led by the Producer Price Index (PPI) and Retail Sales figures. Today, the currency pair will be watching a new round of US economic releases, led by weekly unemployment claims and durable goods orders, scheduled for 03:30 PM Egypt time. Later, there will be new statements from European Central Bank (ECB) Governor Lagarde.

EUR/USD Forecast: Prices Remain Steady Near 1.15

According to Forex currency market trading, the EUR/USD exchange rate tested the 1.15 level, as market volatility and fading expectations for a Federal Reserve rate cut in December contributed to lifting the value of the US Dollar. Regarding the future of the EUR/USD price, global banks remain divided, with near-term pressures contrasting with medium-term expectations pointing to a recovery above the 1.20 psychological resistance level.

Now, Financial markets are focused on the uncertainty regarding Federal Reserve policy and changing interest rate differentials to assess the next move. Following initial currency weakness, Danske Bank expects EUR/USD to rise to 1.22 over a 12-month period. For its part, Morgan Stanley sees the potential for EUR/USD to rise to 1.23 by the second quarter of 2026 before receding to 1.16 by the end of 2026. They anticipate further net losses to 1.14 by the end of the following year.

The movement of the technical indicators on the daily chart is still in the bearish territory: the 14-day Relative Strength Index (RSI) is around a reading of 47, below the neutral line of 50, and at the same time, the MACD indicator lines are still on their downward slope. Over the same timeframe, the 1.1800 psychological resistance will remain the key to changing the overall trend to ascending.

US Monetary Policies and Their Impact on Currency Prices

Regarding the factors influencing currency prices: Following the US jobs data and Federal Reserve minutes, expectations for a Fed rate cut at the December monetary policy meeting saw a further decline, which supported the US currency. In this regard, Danske Bank commented: “We still see EUR/USD on an upward trajectory in the medium term, supported by narrowing interest rate differentials, a recovery in the European asset market, reduced global demand for restrictive policies, continued tailwinds from hedge ratio adjustments, and reduced confidence in US institutions.”

Overall, a high degree of uncertainty remains regarding the US Federal Reserve’s policy in the medium term. Regarding the future of the bank’s policies, UBS Bank commented: “The appointment of a new Fed Chairman could also change policy expectations, potentially leading to lower US interest rates than currently expected. Additionally, the continuation of the US double deficit means the country must continue to attract external funding, which could put further pressure on the US Dollar, especially in the scenario mentioned above.”

Trading Advice:

Do not be deceived, as EUR/USD gains are still limited and unstable and need more stimulus to become stronger and sustained.

Ready to trade our Forex daily analysis and predictions? Here are the best trading platform for beginners to choose from.

Source link

26 11, 2025

‘Jemdangang’ Natural Green Tea launched in Mokokchung | MorungExpress

By |2025-11-26T17:39:07+02:00November 26, 2025|Dietary Supplements News, News|0 Comments


Rev Dr L Kari Longchar officially released and dedicated ‘Jemdangang’ natural green tea in the presence of producers and attendees during a programme held at Mercy Home, Sangtemla Ward, Mokokchung, on November 26. (Morung Photo)

Morung Express News 
Mokokchung | November 26

Jemdangang, a natural green tea cultivated in the Wameken Valley under Mokokchung’s Tuli Subdivision, was formally dedicated and launched on Wednesday during a programme held at Mercy Home, Sangtemla Ward, Mokokchung.

Speaking at the event, Lima Longchar shared the journey behind the product’s development. The plantation, located at Tuli’s 10th Mile—about a kilometre from the Tuli railway station—is jointly cultivated by three families: 2 hectares under his care, a little over 1 hectare by Lanu Atsongchanger, and 1 hectare by Rev Dr Mar Pongener, General Secretary of the NBCC.

He recounted that the group had initially considered other plantations before deciding on tea. “From the first day we started organic and registered with the Tea Board of India, Jorhat, who also advised us to remain fully organic,” he said. Although the plantation has existed for eight years, plucking began only last year. The absence of an organic tea factory in the region forced them to send their leaves to non-organic processing units, causing considerable financial losses.

The cultivators had briefly considered shifting to non-organic methods, but the risks were too high, while continuing organic cultivation meant expensive transportation. Setting up their own factory was also beyond their financial capacity. After undertaking exposure visits to Assam and to local plantations, the team developed a handmade machine and began small-scale trial production. The name Jemdangang, he added, was coined five years ago by Sentila, wife of Rev Dr Pongener.

Releasing the product and offering the dedicatory prayer, Rev Dr L Kari Longchar commended the effort as a promising example of local enterprise in a state that has long relied heavily on outside support. He stressed the need for individuals, families, villages, and the state to work towards self-sufficiency.

Although Nagaland has abundant resources, he observed, many remain underutilised, creating dependence on established systems and “readymade” assistance. While growing numbers of people express the desire to return to their villages and reconnect with their land, he emphasised that genuine productivity requires skill, scientific knowledge, and practical guidance.

Using Jemdangang as an example, Rev Dr Longchar highlighted the importance of efficient production and strong marketing across all sectors. He expressed hope that the tea would not only serve nearby towns but eventually expand to wider, even international, markets. He reminded youth that reaching beyond local markets is ultimately their responsibility.

Reflecting on the decades since Nagaland attained statehood, he cautioned against what he described as a developing “beggar mentality,” where people expect benefits without contributing through hard work. With determination and God-given strength, he said, every individual is capable of earning a dignified livelihood. He urged all to prioritise productive work to reduce dependency and strengthen a more self-reliant society.

Jemdangang is currently available at Urban Oasis and Unique Bakery, with proposals underway for placement at Vishal Megamart. A stall will also operate during the Hornbill Festival, and supplies to Kohima stores are expected to begin next week. The tea is priced at Rs 3,500 per kg and also comes in 70-gram packs for Rs 250. Though grown organically, the tea cannot yet be officially labelled “organic” as certification requires a three-year process now in progress. The producers stated that plans are underway to introduce Jemdangang to international markets soon.



Source link

26 11, 2025

Polygon (MATIC) Price Prediction: Bitcoin Hyper (HYPER) Offers

By |2025-11-26T17:32:07+02:00November 26, 2025|Crypto News, News|0 Comments

Polygon (MATIC) Price Prediction

This briefing outlines a clear Polygon (MATIC) price prediction and frames a comparative case for Bitcoin Hyper (https://bitcoinhyper.com/) as a crypto alternative growth opportunity. U.S. investors face choices between an established Layer-2 token like MATIC and higher-risk, payment-focused presale tokens that promise merchant adoption and payments utility.
We summarize recent market context, on-chain signals, and technical indicators that shape the MATIC outlook and Layer-2 price prediction. Then we contrast those drivers with the mechanics of a payment-token presale, using SpacePay’s published presale terms as an example to highlight tokenomics, presale price ($0.004210), supply distribution, and live testnet availability on Base Sepolia and Ethereum Sepolia.
The comparison focuses on measurable differences: exchange listings and liquidity that support a MATIC forecast versus presale economics, projected merchant cost-savings, and integration claims that underpin Bitcoin Hyper HYPER’s pitch. For U.S. investors, regulatory context and portfolio allocation trade-offs are central-balancing established network effects against potential upside from merchant-facing payment tokens.
Practical participation steps appear throughout the article, including wallet setup, supported payment types, and presale mechanics. This article aims to deliver an objective, news-style briefing to inform a MATIC forecast with parallel consideration of Bitcoin Hyper (https://bitcoinhyper.com/) as a crypto alternative growth path.

Polygon (MATIC) Price Prediction – market drivers, technicals, and on-chain signals

The MATIC market context sits at the intersection of broader crypto macro trends and specific network demand. U.S. investor sentiment often drives short-term flows, while Layer-2 adoption trends determine longer-term utility. Cross-chain activity can shift volume between Polygon, Ethereum, and BNB Chain, changing fee demand and trader interest.

Current market context for MATIC

Exchange flow data shows periods of net inflows and outflows that correlate with risk-on and risk-off episodes. When macro liquidity is ample, wallet adoption and dApp growth Polygon metrics tend to rise. Rising gas on Ethereum renews attention on Layer-2 adoption and boosts on-chain transactions on Polygon.

Technical indicators and short-to-medium term scenarios

MATIC technical analysis begins with moving averages MATIC such as the 50-, 100-, and 200-day MA to define trend bias. Traders watch support and resistance MATIC zones from prior accumulation areas and recent swing highs. RSI MACD volume readings help time entries: an RSI near neutral with rising volume and a bullish MACD crossover points to continuation.

Short-to-medium term scenarios depend on combined signals. Bullish paths require price to stay above key moving averages MATIC while on-chain activity and wallet adoption trend up. A consolidation outcome looks likely if volume drops and RSI moves sideways. A deeper correction may follow large net outflows to exchanges or a broad sell-off tied to worsening crypto macro trends.

On-chain fundamentals and ecosystem catalysts

MATIC on-chain fundamentals include active addresses, transaction throughput, and bridge transfer volumes. Growth in unique wallets and smart contract deployments supports higher utility. dApp growth Polygon, measured by DeFi TVL and NFT marketplace volume, strengthens demand for MATIC fees and staking.

Polygon ecosystem catalysts to monitor include major dApp launches, enterprise integrations, and protocol updates that affect tokenomics. Cross-chain bridges and multi-chain wallet support lower friction for users and can increase composability. Off-chain signals such as exchange listings and GitHub developer activity often precede larger shifts in network use.

Traders combine technical signals with on-chain alerts like whale transfers and sustained wallet accumulation to adjust probability-weighted price paths. Watching these elements together gives a clearer view of how U.S. investor sentiment and global market drivers may shape MATIC’s next moves.

Bitcoin Hyper (HYPER) Offers Alternative Growth – comparative case for investors

The rise of payment-focused tokens presents a different thesis from Layer‐2 plays like Polygon. Bitcoin Hyper (https://bitcoinhyper.com/) aims to capture real-world transactions with a payment token utility that targets merchants and point-of-sale flows rather than purely on‐chain gas fees. Investors evaluating MATIC vs presale risk can weigh direct merchant benefits against established network usage patterns.

What Bitcoin Hyper brings to market centers on practical merchant economics. The SpacePay model provides a concrete example: a final presale price of $0.004210, more than $1.4M raised, and a 34 billion token supply split across public presale (20%), loyalty/rewards (17%), partnerships (18%), marketing (18%), platform development (10%), founding team (5%), and strategic reserves (12%). These presale tokenomics influence early allocation and initial market supply, and they shape post‐listing price discovery.

Cross‐chain functionality matters for adoption. Bitcoin Hyper emphasizes compatibility across Ethereum, Polygon, and BNB Chain, with wallet support for over 325 wallets. Live testnets on Base Sepolia and Ethereum Sepolia give verifiable technical progress. Payment processor crypto projects that show working testnets reduce uncertainty about implementation timelines and merchant onboarding.

Merchant adoption hinges on merchant crypto payments mechanics and settlement design. The SpacePay example offers instant fiat settlement at the time of transaction so merchants never hold crypto exposure. That fiat settlement crypto feature and a payment processor crypto fee around half a percent can cut costs versus card processors that charge higher percentages and fixed fees. Lower fees and fast local currency payouts create stronger merchant adoption SpacePay signals than speculative utility alone.

Governance and revenue sharing add investor appeal. Token holders receive voting rights on product priorities and monthly distributions tied to transaction volume. These mechanics align holder incentives with real usage and reduce reliance on secondary‐market speculation for returns. Such structures affect HYPER risk reward because they link token economics to payment flows.

Comparing utility and merchant‐facing adoption shows clear contrasts. MATIC’s core utility remains network fees and gas for DeFi, NFTs, and dApp activity. Merchant crypto payments demand different integrations: software upgrades instead of hardware swaps, automatic currency conversion, and instant fiat settlement. These features lower friction for retailers and emphasize real-world spending adoption rather than developer activity.

Presale dynamics drive both upside and risk. Early access pricing and allocation percentages can boost early returns, yet liquidity risk presale and token volatility are elevated. Emerging presale tokens face uncertain exchange listing timelines, low initial liquidity, and higher short‐term volatility. Investors should track presale metrics, testnet proofs, merchant pilot results, and planned exchange listings.

Risk vectors for payment tokens include merchant onboarding success, measurable payment volume, and the robustness of instant fiat settlement. Team credibility and working testnets matter for reducing execution risk. Token design choices like a 5% founding team allocation and 12% strategic reserves influence concentration and long‐term alignment, and they shape investor perception of HYPER (https://bitcoinhyper.com/) risk reward.

Established tokens such as MATIC reduce some tail risks through liquidity, broad exchange listings, and a large developer ecosystem. That on‐chain usage offers different protections compared with nascent payment tokens that seek merchant traction. MATIC vs presale risk comparisons therefore come down to whether an investor prioritizes proven liquidity and ecosystem depth or higher early upside tied to merchant adoption.

Investors should balance presale tokenomics and the SpacePay model’s real‐world proofs against token volatility and liquidity risk presale. Early revenue share and discounted entry may appeal to growth seekers, while those focused on downside protection may prefer mature network tokens with clearer market depth and predictable on‐chain demand.

Investment considerations for U.S. investors: portfolio allocation, presales, and regulatory context

U.S. investors weighing exposure to MATIC or newer payment tokens should start with clear allocation rules. Treat established tokens like Polygon (MATIC) as core positions for liquidity and ecosystem access, and size speculative presale stakes to match your risk tolerance and time horizon. Token allocation impact is immediate: a public presale buyer holding 20% of supply will influence short-term circulating supply and liquidity after listing, so plan position sizes accordingly.

Presale participation requires practical steps to reduce avoidable errors. Use trusted wallets such as MetaMask or WalletConnect and verify official smart contract addresses before sending funds. Commonly supported payment types include ETH, BNB, MATIC, AVAX, USDT, and USDC. Confirm the presale domain and contract details, and record the example entry pricing-an early presale at $0.004210 highlights how initial pricing and allocation breakdowns shape future price discovery.

Regulatory and custody risks are central for U.S. buyers. Presale regulatory risk can arise if token economics resemble securities; evaluate utility, revenue-sharing, and team disclosures. Exchanges may delay or block listings for regulatory reasons, and some centralized platforms restrict U.S. participation. Consider custody options carefully and consult legal and tax professionals about KYC/AML rules and potential tax liabilities tied to presale investment US.

After purchase, monitor merchant adoption metrics and on-chain signals. Track transaction volume growth, merchant onboarding rates, monthly distributions to token holders, order book depth and spreads, active addresses, and developer commits. Merchant integration often requires testing, staff training, and settlement workflows despite claims of no hardware changes; instant fiat settlement features can mitigate volatility and speed cash flow. These operational realities affect adoption timelines and return potential for payment-focused projects.

Buchenweg 15, Karlsruhe, Germany

For more information about Bitcoin Hyper (HYPER) visit the links below:

Website: https://bitcoinhyper.com/

Whitepaper: https://bitcoinhyper.com/assets/documents/whitepaper.pdf

Telegram: https://t.me/btchyperz

Twitter/X: https://x.com/BTC_Hyper2

Disclosure: Crypto is a high-risk asset class. This article is provided for informational purposes and does not constitute investment advice.

CryptoTimes24 is a digital media and analytics platform dedicated to providing timely, accurate, and insightful information about the cryptocurrency and blockchain industry. The enterprise focuses on delivering high-quality news coverage, market analysis, project reviews, and educational resources for both investors and enthusiasts. By combining data-driven journalism with expert commentary, CryptoTimes24 aims to become a trusted global source for emerging trends in decentralized finance (DeFi), NFTs, Web3 technologies, and digital asset markets.

This release was published on openPR.

Source link

26 11, 2025

El VIH y el riesgo de otros problemas médicos

By |2025-11-26T17:11:19+02:00November 26, 2025|Fitness News, News|0 Comments

English

El 1 de diciembre de 2025 es el Día Mundial del SIDA.

Gracias al tratamiento denominado terapia antirretroviral (TAR), personas con asignación femenina cuando nacieron (AFAB, por sus siglas en inglés) y mujeres con VIH ahora viven (¡y tienen éxito!) hasta la vejez. Más de la mitad de personas con VIH en Estados Unidos tienen 50 años o más. Pero el VIH se asocia a ciertos problemas médicos que pueden afectar a mujeres que viven con esa enfermedad. Aquí encontrarás algunos de los más comunes.

Problemas médicos ginecológicos y el VIH

Los problemas médicos ginecológicos son los que afectan el sistema reproductivo femenino. Para mujeres y personas AFAB que viven con VIH, estos podrían incluir:

  • Infecciones de transmisión sexual (ITS) tales como herpes, la enfermedad pélvica inflamatoria (EPI) y sífilis
  • La candidiasis vulvovaginal, también conocida como candidiasis vaginal
  • La vaginosis bacteriana (VB), otra infección que afecta la vagina

Las personas con VIH son más vulnerables a estos problemas porque el VIH debilita el sistema inmunológico, lo que hace que sea más difícil para el cuerpo combatir las infecciones.

El VIH también puede afectar el ciclo menstrual y podría causar:

  • Períodos menstruales irregulares
  • La omisión de períodos menstruales
  • Manchado (sangrado leve entre los períodos menstruales)
  • Síndromes premenstruales (SPM) graves

Mayor riesgo de cáncer cervical

El cáncer cervical empieza en el cuello uterino, la parte inferior del útero que se conecta con la vagina. Usualmente lo causan infecciones con ciertos tipos de virus del papiloma humano (VPH).

La infección del VPH es tan común que la mayoría de personas que no se vacunaron contra esta enfermedad se infectarán en algún momento sin enterarse de que lo portan. Pero los sistemas inmunológicos de las mujeres que viven con VIH podrían tener más dificultad para liberarse del VPH, lo cual incrementa su riesgo de desarrollar cáncer cervical.

Lee: Información resumida: Aquí encontrarás lo que debes saber sobre el cáncer cervical y el VPH >>

Mayor riesgo de problemas cardíacos

Las enfermedades cardíacas son la causa más importante de muertes para mujeres en Estados Unidos y las enfermedades cardíacas relacionadas con el VIH son la causa principal de muertes de mujeres con VIH. El riesgo de tener un ataque cardiaco es particularmente alto para mujeres con VIH, quienes son tres veces más propensas a tener un ataque cardiaco que mujeres sin VIH.

Científicos piensan que varios factores podrían contribuir con esto, incluyendo inflamaciones crónicas y activaciones inmunitarias del VIH, los efectos de algunos medicamentos contra el VIH en el colesterol y el azúcar en la sangre, factores de riesgo generales (tales como hipertensión y fumar) y, para algunas mujeres, cambios hormonales relacionados con la menopausia.

Efectos colaterales e interacciones de medicamentos contra el VIH

Si bien la TAR funciona bien para mantener al VIH bajo control, también tiene efectos colaterales que varían dependiendo del medicamento. Efectos colaterales relativamente menores podrían incluir:

  • Alteración estomacal
  • Dolores de cabeza
  • Boca seca
  • Problemas de sueño
  • Cambios de estado de ánimo
  • Cansancio
  • Mareo
  • Fatiga

Medicamentos que se usan para tratar el VIH también se asocian a efectos colaterales más graves, incluyendo depresión, colesterol alto, síndrome del segmento QT largo (un tipo mortal de ritmo cardiaco anormal), un mayor riesgo de pancreatitis (inflamación repentina del páncreas) y osteoporosis.

Otra preocupación para mujeres que se someten a TAR son las interacciones medicamentosas, es decir, la forma en que estos tratamientos afectan cualquier otro medicamento que podrían tomar y viceversa.

La TAR podría evitar que otros medicamentos que tomes funcionen adecuadamente o hacer que tu cuerpo absorba demasiado medicamento. Y algunos medicamentos (tales como los inhibidores de la bomba de protones o IBP que comúnmente se toman para acidez) podrían evitar que tu cuerpo asimile la TAR adecuadamente.

Es importante para mujeres con VIH hablar con un proveedor de atención médica (HCP, por sus siglas en inglés) o con un farmacéutico antes de empezar a tomar un medicamento nuevo, incluso si es un suplemento o si se vende sin receta médica, para que verifiquen si podrían haber posibles interacciones medicamentosas.

La menopausia y otros asuntos relacionados con la edad

A medida que las personas AFAB y mujeres con VIH atraviesan la menopausia, podrían tener más dificultades con la transición que otras personas que no tienen esa enfermedad. Podrían experimentar la menopausia antes y sus síntomas (tales como bochornos y sudores nocturnos) podrían ser peores.

La menopausia no es el único cambio de la salud asociado con la edad que podría ocurrir antes, en promedio, para mujeres con VIH. Un estudio determinó que trastornos comunes que se relacionan con la edad tales como enfermedades renales y la diabetes ocurrieron 16 años antes en personas con VIH que en personas sin esa enfermedad.

Los expertos no saben exactamente porque las personas con VIH resultan más afectadas por estos trastornos, pero piensan que la inflamación causada por el virus podría ser un factor importante.

Vivir lo mejor posible con VIH

Gracias a la medicina moderna, personas con VIH están disfrutando vidas más largas y plenas. Y si bien la enfermedad implica algunos desafíos únicos para personas AFAB y mujeres, hay recursos disponibles que pueden ser útiles para manejarlos.

Organizaciones tales como Older Women Embracing Life (OWEL) proporcionan asistencia a mujeres que viven con VIH, así como a sus familias y cuidadores. También puedes hablar con tu proveedor de atención médica acerca de lo que podrías hacer para mantenerte lo más saludable posible a medida que avanzas a tus años dorados.

Este recurso educativo se preparó con el apoyo de Merck.

From Your Site Articles

Related Articles Around the Web



Source link

26 11, 2025

DeFi Technologies Announces Landmark Milestone for Venture Portfolio Company Stablecorp as QCAD Becomes Canada’s First Compliant CAD Stablecoin

By |2025-11-26T16:15:16+02:00November 26, 2025|News, NFT News|0 Comments


DeFi Technologies Inc./ Key word(s): Private Equity/Expansion

DeFi Technologies Announces Landmark Milestone for Venture Portfolio Company Stablecorp as QCAD Becomes Canada’s First Compliant CAD Stablecoin

26.11.2025 / 13:35 CET/CEST

The issuer is solely responsible for the content of this announcement.

TORONTO, Nov. 26, 2025 /PRNewswire/ — DeFi Technologies Inc. (the “Company” or “DeFi Technologies“) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”), is pleased to announce that its venture portfolio company Canada Stablecorp Inc. (“Stablecorp“) and the QCAD Digital Trust have achieved a significant national milestone, with QCAD approved as Canada’s first compliant CAD stablecoin.

Stablecorp announced that, following a multi-year regulatory approval process, the QCAD Digital Trust has received a final receipt for the prospectus qualifying the distribution of QCAD tokens pursuant to Canada’s current regulatory framework for stablecoins. This milestone establishes a new benchmark for compliant, CAD-denominated digital money and lays the groundwork for broader adoption of tokenized Canadian dollars across payments and capital markets.

Stablecorp is part of DeFi Technologies’ venture portfolio, following the strategic investment and commercial collaboration first announced on September 25, 2025. Through this partnership, DeFi Technologies intends to help scale QCAD as a core Canadian-dollar rail across its product and trading platform.

How DeFi Technologies Plans to Support QCAD

DeFi Technologies and Stablecorp intend to focus on scaling QCAD across three core areas:

  • Product development:DeFi Technologies, directly and through Valour Inc. (“Valour”), plans to develop QCAD-integrated products, including CAD-linked ETPs, yield products, and structured solutions that provide regulated access to the digital asset economy for retail and institutional investors.
  • Liquidity and market access:DeFi Technologies is positioned as a preferred liquidity provider for QCAD, supporting institutional-grade execution, on/off-ramps, and mint/redeem flows in key corridors such as Canada–U.S. trade and cross-border payments.
  • Security and future-proofing:In coordination with BTQ Technologies Corp. (“BTQ”), a quantum security leader and partner to DeFi Technologies, the Company intends to support the development of a post-quantum security roadmap for QCAD as volumes and systemic importance scale over time.

“With this milestone, we have laid the rails for a new financial system—one that is more open, efficient, and accessible for every Canadian,” said Kesem Frank, Stablecorp CEO. “We are excited to work with our DeFi Technologies partners in positioning QCAD as more than just a token; rather as a key to unlocking Canada’s digital potential.”

“QCAD’s approval as Canada’s first compliant CAD stablecoin is a pivotal milestone for Stablecorp and for the Canadian digital asset market,” said Johan Wattenström, Chief Executive Officer and Executive Chairman of DeFi Technologies. “Having a fully regulated Canadian-dollar rail fits squarely within our strategy of backing category-defining infrastructure and allows us to support QCAD’s growth across our platform and our broader institutional network.”

“From a business perspective, QCAD gives us a powerful building block for the next phase of DeFi Technologies’ growth,” said Andrew Forson, President of DeFi Technologies. “We see opportunities to launch CAD-linked ETPs and structured products, deepen institutional on- and off-ramp flows, and ultimately create new, recurring fee and spread revenue streams, all while aligning with Canada’s evolving regulatory framework for digital assets.”

About the QCAD Digital Trust and Stablecorp

The QCAD Digital Trust is an Ontario trust that holds the reserve assets on behalf of holders of QCAD. Stablecorp is one of Canada’s leading digital asset infrastructure companies, focused on building professional-grade blockchain solutions. In partnership with industry leaders, Stablecorp creates refined, scalable and compliant products, such as QCAD, that serve as the foundation for the next generation of financial services. Further information about QCAD, including the reserve assets and the terms and conditions associated with the QCAD program can be found on the Stablecorp website (www.stablecorp.ca) and under the trust’s profile on SEDAR+ at www.sedarplus.ca.

About DeFi Technologies

DeFi Technologies Inc. (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B) is a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”). As the first Nasdaq-listed digital asset manager of its kind, DeFi Technologies offers equity investors diversified exposure to the broader decentralized economy through its integrated and scalable business model. This includes Valour, which offers access to one hundred of the world’s most innovative digital assets via regulated ETPs; Stillman Digital, a digital asset prime brokerage focused on institutional-grade execution and custody; Reflexivity Research, which provides leading research into the digital asset space; Neuronomics, which develops quantitative trading strategies and infrastructure; and DeFi Alpha, the Company’s internal arbitrage and trading business line. With deep expertise across capital markets and emerging technologies, DeFi Technologies is building the institutional gateway to the future of finance. Follow DeFi Technologies on LinkedIn and X/Twitter, and for more details, visit https://defi.tech/ 

DeFi Technologies Subsidiaries

About ValourValour Inc. and Valour Digital Securities Limited (together, “Valour“) issues exchange traded products (“ETPs”) that enable retail and institutional investors to access digital assets in a simple and secure way via their traditional bank account. Valour is part of the asset management business line of DeFi Technologies. For more information about Valour, to subscribe, or to receive updates, visit valour.com.

About Stillman DigitalStillman Digital is a leading digital asset liquidity provider that offers limitless liquidity solutions for businesses, focusing on industry-leading trade execution, settlement, and technology. For more information, please visit https://www.stillmandigital.com

About Reflexivity ResearchReflexivity Research LLC is a leading research firm specializing in the creation of high-quality, in-depth research reports for the bitcoin and digital asset industry, empowering investors with valuable insights. For more information please visit https://www.reflexivityresearch.com/ 

Cautionary note regarding forward-looking information: This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to commercial collaborations with Stablecorp and BTQ; regulation and scaling of the QCAD stablecoin; investor confidence in digital assets generally; the regulatory environment with respect to the growth and adoption of decentralized finance; the pursuit by the Company and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited the acceptance of Valour exchange traded products by exchanges; growth and development of decentralised finance and digital asset sector; rules and regulations with respect to decentralised finance and digital assets; fluctuation in digital asset prices; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

THE CBOE CANADA EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Logo – https://mma.prnewswire.com/media/2832542/DeFi_Technologies_Inc__DeFi_Technologies_Announces_Landmark_Mile.jpg

View original content:https://www.prnewswire.com/de/pressemitteilungen/defi-technologies-announces-landmark-milestone-for-venture-portfolio-company-stablecorp-as-qcad-becomes-canadas-first-compliant-cad-stablecoin-302626546.html

26.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

View original content: EQS News

2236302 26.11.2025 CET/CEST

Disclaimer

Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.



Source link

26 11, 2025

Copper price repeats the positive closes– Forecast today – 26-11-2025

By |2025-11-26T16:09:04+02:00November 26, 2025|Forex News, News|0 Comments


Despite the weakness of copper prices in the last period, its stability within the main bullish channel’s levels, and holding above $4,7500, supports the chances of renewing the bullish attempts, to settle near $5.0500.

 

Facing the barrier at $5.2000 by the main indicators confirms the importance of surpassing it to open the way for recording extra gains that might begin at $5.3200 and $5.5000.

 

The expected trading range for today is between $4.9500 and $5.2000

 

Trend forecast: Bullish





Source link

Go to Top